SCHEMBL30846261

SCHEMBL30846261

CCc1ccc2cnn(C)c2c1NS(=O)(=O)c1cnc(Cl)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 2/20 0.41
▸ OXTR P30559 1/20 0.37
▸ AVPR1A P37288 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NMT1 P30419 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ CCR1 P32246 1/20 0.31
▸ CCR2 P41597 1/20 0.31
▸ CCR4 P51679 1/20 0.31
▸ TUBB4A P04350 1/20 0.31
▸ TUBB P07437 1/20 0.31
▸ TUBA3C P0DPH7 1/20 0.31
▸ TUBA1B P68363 1/20 0.31
▸ TUBA4A P68366 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27121169 1.00 SLC40A1 (0.41) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL30846429 0.88 KDM4E (0.43) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL27144846 0.88 KDM4E (0.43) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL27137458 0.80 SLC40A1 (0.38) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL30847864 0.80 SLC40A1 (0.38) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL27214916 0.79 SLC40A1 (0.39) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL30846294 0.79 SLC40A1 (0.39) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL27121198 0.79 OXTR (0.38) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL30846487 0.79 OXTR (0.38) SLC40A1OXTRAVPR1ALMNAHTT
SCHEMBL27121152 0.79 NMT1 (0.33) SLC40A1OXTRAVPR1ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback